HTLF, US42223A1079

Heartflow stock hits new 52-week high as CFO sells shares worth over USD 1.2 million

Published on 09/19/2026 at 14:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Heartflow stock reached a new 52-week high of USD 52.22 on September 18, 2026, with trading volume far above average. The move coincided with CFO Vikram Verghese selling 24,345 shares under a Rule 10b5-1 plan in mid-September 2026.

HTLF, US42223A1079, Illustration mit AI erstellt.
HTLF, US42223A1079, Illustration mit AI erstellt.

Heartflow, Inc. stock (ISIN US42223A1079) climbed to a new 52-week high of USD 52.22 on September 18, 2026, on Nasdaq, with the last trade reported around USD 51.20 and volume significantly above its recent average, according to data cited by MarketBeat on September 18, 2026.

Stock rallies to fresh high amid heavy trading

As MarketBeat reported on September 18, 2026, Heartflow shares traded as high as USD 52.22 during the session and last changed hands at roughly USD 51.20, compared with a prior close of USD 49.57, implying an intraday gain of about 3.3 percent on the day.

In the same report, MarketBeat highlighted that roughly 1,599,729 Heartflow shares traded on September 18, 2026, compared with an average daily volume of about 1,824,326 shares, signalling robust investor interest as the stock approached and briefly surpassed its 12-month high.

CFO share sales near the high add a risk angle

The price strength coincided with sizeable insider selling by Chief Financial Officer Vikram Verghese, who executed planned share sales under a Rule 10b5-1 trading plan adopted on June 4, 2026, according to StockTitan on September 19, 2026.

According to StockTitan, Verghese sold a total of 24,345 Heartflow shares in two transactions, disposing of 7,579 shares on September 17, 2026 at a weighted average price of USD 50.1142 and 16,766 shares on September 18, 2026 at a weighted average price of USD 50.7531.

The Form 4 filing shown by StockTitan details that trades on September 17, 2026 occurred within a price range of USD 50.00 to USD 50.29, while trades on September 18, 2026 were executed between USD 50.00 and USD 52.11, placing the sales close to the fresh 52-week high of USD 52.22 cited by MarketBeat.

Analyst targets trail the latest price move

Beyond the insider activity, valuation metrics show that the market price has moved ahead of the average analyst target, which may influence investor expectations. According to data referenced by MarketBeat on September 18, 2026, Heartflow carries an average rating of Moderate Buy with a consensus price target of USD 44.88 per share.

With the stock last trading around USD 51.20 on September 18, 2026, the market price stands roughly 14.1 percent above the average analyst target of USD 44.88 cited by MarketBeat, underscoring that recent momentum has outpaced the Street’s baseline expectations.

This divergence between price and consensus target could be perceived as a risk factor, especially when combined with the CFO’s sales close to the high; however, the Rule 10b5-1 framework documented by StockTitan suggests the trades were pre-planned rather than discretionary timing decisions.

Closing price context for Heartflow stock

Per Nasdaq trading data referenced by MarketBeat, Heartflow stock closed at USD 49.57 on Nasdaq on September 17, 2026 and then finished the September 18, 2026 session near USD 51.20 after touching the 52-week high of USD 52.22, leaving the shares slightly below that intraday peak but clearly above the prior close.

Heartflow stock key data

  • Company: Heartflow, Inc.
  • ISIN: US42223A1079
  • Ticker: HTFL
  • Trading venue: Nasdaq
  • Price (as of September 18, 2026): 51.20 USD
  • Market capitalization: [value] USD (as of September 18, 2026)
  • Sector / Industry: Health Care Technology
  • Index membership: Nasdaq Composite

More news and analyses on Heartflow stock

Disclaimer...

en | US42223A1079 | HTLF | boerse | 70131861 | bgmi